Published on March 17, 2010 at 2:21 AM
Aegis
Analytical Corp., the leading
provider of Enterprise Manufacturing Intelligence software, announced
today that Human Genome Sciences, Inc. will deploy Aegis’ Discoverant®
as its data management, analytics and reporting solution in the
scale-up and production of BENLYSTA™ (belimumab), an
investigational drug for the treatment of systemic lupus that has
successfully completed Phase 3 trials. The submission of marketing
applications for BENLYSTA is planned in the U.S., Europe and other
regions in the second quarter of 2010.
Source Human Genome Sciences